An Evaluation of the Tobacco Prevention Toolkit Healthy Futures: Alternative-to-Suspension Vaping Intervention
Launched by STANFORD UNIVERSITY · Jun 26, 2024
Trial Information
Current as of July 24, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a program called the Healthy Futures: Alternative-to-Suspension Curriculum, which is designed to help high school students quit using tobacco and vaping products. The goal is to see how well this online program can improve students' understanding of the risks of tobacco use, change their attitudes towards it, and ultimately reduce their use of these products.
To take part in this study, schools need to agree to either use the Healthy Futures program or continue with their usual approach to handling tobacco use. The students who can participate are those aged 14 to 18 who are in grades 9-12 and are willing to share their experiences with tobacco use. Participants will complete online surveys before and after the program to help researchers understand its impact. It's important to note that parents will need to give permission for their children to participate if required, and the study aims to benefit public health in schools.
Gender
ALL
Eligibility criteria
- • Inclusion criteria for schools
- • Agree to be randomized to use the Healthy Futures: Alternative-to-Suspension curriculum or to use their current standard of care exclusive of Healthy Futures: Alternative-to-Suspension
- • Agree that teachers, counselors, or other school personnel will schedule an online survey prior to and after implementation of Healthy Futures: Alternative-to-Suspension or current standard of care with students caught using e-cigarettes or other tobacco products and with students self-reporting use of those products and seeking help to quit
- • Has access to a school nurse/school health officer/school counselor or school psychologist
- • Agree that parental consent, where required, will be sought from students prior to survey administration.
- • Agree that the study is in the wider interest of the public health of adolescents and in their schools interest.
- • Inclusion criteria for participants Adolescents, aged 14-18, from grades 9-12, who are agreeable to participate in the study and provide assent.
- Exclusion Criteria:
- • Adolescents, aged 14-18 years, from grades 9-12 who do not speak English.
About Stanford University
Stanford University is a prestigious academic institution renowned for its cutting-edge research and innovation in healthcare and medicine. As a clinical trial sponsor, Stanford leverages its extensive resources, including a collaborative network of world-class researchers and state-of-the-art facilities, to advance medical knowledge and improve patient care. The university is committed to conducting rigorous, ethical research that adheres to the highest standards of scientific integrity, fostering an environment where groundbreaking discoveries can translate into effective clinical applications. Through its clinical trials, Stanford aims to address critical health challenges and contribute to the development of novel therapies and treatment strategies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Palo Alto, California, United States
Patients applied
Trial Officials
Bonnie Halpern-Felsher, Ph.D
Principal Investigator
Stanford University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported